Autres langues Pfizer Limited Bombay S.E.

Actions

PFIZER

INE182A01018

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:50 26/04/2024			Varia. 5j.	Varia. 1 janv.
4 195 ^INR	+1,50 %		+1,83 %	-1,72 %

02/04	Pfizer Limited nomme Amit Agarwal directeur à temps plein, désigné comme directeur exécutif des finances	CI
28/03	L'administration nationale chinoise des produits médicaux accepte la demande supplémentaire de licence biologique d'Astellas et de Pfizer pour Enfortumab Vedotin avec Keytruda (Pembrolizumab) pour le traitement de première ligne du cancer avancé de la vessie	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Pfizer Limited Appoints Amit Agarwal as Chief Financial Officer	02/04
Pfizer Limited Appoints Amit Agarwal as Whole-Time Director, Designated as Executive Director Finance	02/04
China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for Enfortumab Vedotin with Keytruda (Pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer	28/03
Pfizer Limited Receives an Order from Joint Commissioner of State Tax Basis the GST Audit Conducted for Uttar Pradesh State for the Financial Year 2018-19	22/03
Pfizer Limited Receives an Order from Deputy Commissioner of State Tax Basis the GST Audit Conducted for the Financial Year 2018-19	19/03
Pfizer Limited Informs Satyen Amin, Lead - Market Access Tenders His Resignation from Employment, with Effect from March 31, 2024	09/02
Pfizer Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02
Pfizer Ltd. Names CFO	22/01
Pfizer CFO Retires	01/12
Pfizer Limited Announces Retirement of Mr. Milind Patil as Chief Financial Officer	30/11
Pfizer Limited Appoints Ms. Aditi Mehta as Category Lead, Vaccines Effective December 1, 2023	16/11
Pfizer Limited Announces Resignation of Mr. Milind Patil as Director with Effect from Close of Business on November 13, 2023	13/11
Pfizer Sees Sharp Fall in Fiscal Q2 Net Profit	30/10/23
Pfizer Limited Announces Resignation of Samir Kazi as Director from the Board of Directors	28/10/23
Pfizer Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	28/10/23
Pfizer : Annual Return 2022 – 23	17/10/23
Pfizer Limited Appoints Chaitanya Nadkarni as India Digital Client Partner Lead	06/09/23
Pfizer Limited Approves A Final Dividend for the Financial Year Ended March 31, 2023	21/08/23
Pfizer Limited Announces Change in Management, Effective September 1, 2023	18/08/23
Seagen's breast cancer therapy meets main goal in late-stage study	16/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Pfizer Limited Bombay S.E.

Actions

PFIZER

INE182A01018

Autres langues

Filtres